Get the Stockscreener App
79.82
0.06%
0.05
After Hours:
79.82
Lemaitre Vascular Inc stock is traded at $79.82, with a volume of 102.98K.
It is up +0.06% in the last 24 hours and down -2.40% over the past month.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
See More
Previous Close:
$79.77
Open:
$79.78
24h Volume:
102.98K
Relative Volume:
0.62
Market Cap:
$1.80B
Revenue:
$213.03M
Net Income/Loss:
$41.32M
P/E Ratio:
43.62
EPS:
1.83
Net Cash Flow:
$33.49M
1W Performance:
-5.08%
1M Performance:
-2.40%
6M Performance:
-19.90%
1Y Performance:
-7.40%
1-Day Range:
$79.60
$80.65
1-Week Range:
$79.60
$84.78
52-Week Range:
$71.42
$109.58
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Name
Lemaitre Vascular Inc
Sector
Industry
Phone
781-221-2266
Address
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
79.82 | 1.90B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
516.12 | 185.10B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
175.33 | 50.76B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.16 | 43.19B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
261.07 | 37.26B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
210.08 | 16.13B | 2.90B | 467.20M | 306.90M | 6.37 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-28-25 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Feb-28-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-13-25 | Initiated | Wells Fargo | Equal Weight |
| Oct-15-24 | Initiated | Cantor Fitzgerald | Neutral |
| Aug-02-24 | Resumed | Lake Street | Buy |
| May-31-24 | Resumed | ROTH MKM | Buy |
| Apr-26-24 | Upgrade | Stifel | Hold → Buy |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Sector Weight |
| Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-06-23 | Initiated | Oppenheimer | Outperform |
| Aug-03-23 | Downgrade | Jefferies | Buy → Hold |
| May-03-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-28-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-16-21 | Initiated | Jefferies | Buy |
| Feb-12-21 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Mar-16-20 | Upgrade | Sidoti | Neutral → Buy |
| Oct-24-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Oct-24-19 | Upgrade | Lake Street | Hold → Buy |
| Oct-14-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Jul-25-19 | Reiterated | Barrington Research | Outperform |
| Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
| Oct-08-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-08-18 | Upgrade | ROTH Capital | Neutral → Buy |
| Jun-08-18 | Resumed | ROTH Capital | Buy |
| Apr-26-18 | Downgrade | Stifel | Buy → Hold |
| Apr-26-18 | Upgrade | The Benchmark Company | Hold → Buy |
| Oct-27-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Oct-27-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-10-17 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jul-10-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Mar-21-17 | Initiated | First Analysis Sec | Overweight |
| Feb-22-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-22-16 | Downgrade | Sidoti | Buy → Neutral |
| Jul-28-16 | Reiterated | Barrington Research | Outperform |
| Feb-25-16 | Reiterated | Barrington Research | Outperform |
View All
Lemaitre Vascular Inc Stock (LMAT) Latest News
What drives LeMaitre Vascular Inc. stock priceFree Market Dynamics Reports - Autocar Professional
LeMaitre Vascular Inc. Stock Analysis and ForecastRapid-fire capital growth - Autocar Professional
What analysts say about LeMaitre Vascular Inc. stockExceptional profit margins - Autocar Professional
Is LeMaitre Vascular Inc. a good long term investmentHigh-yield growth strategies - Autocar Professional
Bank of New York Mellon Corp Cuts Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
Segall Bryant & Hamill LLC Purchases 17,354 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Alps Advisors Inc. Takes Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Principal Financial Group Inc. Buys 3,248 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
why lemaitre vascular inc. stock attracts strong analyst attentionFree Stock Market Return Analysis - Newser
Is LeMaitre Vascular (NASDAQ:LMAT) A Risky Investment? - simplywall.st
Some Shareholders Feeling Restless Over LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) P/E Ratio - 富途牛牛
Rice Hall James & Associates LLC Sells 24,454 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Investors in LeMaitre Vascular (NASDAQ:LMAT) have seen stellar returns of 208% over the past five years - Yahoo Finance
Trend Tracker for (LMAT) - news.stocktradersdaily.com
Envestnet Asset Management Inc. Has $23.92 Million Stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
What makes LeMaitre Vascular Inc. stock price move sharplyFast Moving Stock Alerts - Newser
How LeMaitre Vascular Inc. stock performs during market volatilityFast Moving Stock Alerts - Newser
Why LeMaitre Vascular Inc. stock attracts strong analyst attentionSmart Money Trade Setups - Newser
Principal Financial Group Inc. Raises Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
Teacher Retirement System of Texas Decreases Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular: High Growth Potential, But Risks Lurk Beneath the Surface - AInvest
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Allspring Global Investments Holdings LLC - Defense World
LeMaitre Will Announce Second Quarter 2025 Earnings Results August 5, 2025 - GlobeNewswire
LeMaitre Vascular, Inc. to Release Q2 2025 Financial Results on August 5, 2025 - Nasdaq
LeMaitre Sets Q2 2025 Earnings Date: How to Join the August 5 Conference Call - Stock Titan
Wealth Enhancement Advisory Services LLC Sells 494 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
Vascular Patches Market Is Booming So Rapidly 2025-2032 -Braun - openPR.com
When (LMAT) Moves Investors should Listen - news.stocktradersdaily.com
LeMaitre Vascular’s SWOT analysis: niche market leader faces growth challenges By Investing.com - Investing.com South Africa
LeMaitre Vascular’s SWOT analysis: niche market leader faces growth challenges - Investing.com Nigeria
Oppenheimer Asset Management Inc. Trims Stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
LeMaitre Vascular (NASDAQ:LMAT) Stock Price Down 3.5%Time to Sell? - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) & Futureworld (OTCMKTS:FWDG) Head-To-Head Survey - Defense World
Consolidated Planning Corp Invests $947,000 in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Johnson Investment Counsel Inc. Raises Stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Farther Finance Advisors LLC Reduces Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
Earnings Not Telling The Story For LeMaitre Vascular, Inc. (NASDAQ:LMAT) - simplywall.st
LeMaitre Vascular: Scaling Nicely As Global Demand Builds (NASDAQ:LMAT) - Seeking Alpha
Lemaitre Vascular Inc Stock (LMAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):